PharmaShots Weekly Snapshots (Mar 01 - 05, 2021)
Published: Mar 5, 2021 | Tags: Eli Lilly and Incyte, Report, Results, Olumiant (baricitinib), P-III, BRAVE-AA2, Study, Severe, Alopecia Areata
Takeda Reports NDA Submission to Import and Distribute Moderna's mRNA-1273 in Japan
Published: Mar 5, 2021 | Tags: Takeda, Reports, NDA, Submission, Import, Distribute, Moderna, mRNA-1273, Japan
Published: Mar 5, 2021 | Tags: Roche, Actemra/RoActemra (tocilizumab), Receives, US, FDA, Approval, First, Biologic, Systemic Sclerosis-Associated Interstitial Lung Disease
Agilent to Acquire Resolution Bioscience for $695M
Published: Mar 5, 2021 | Tags: Agilent, Acquire, Resolution Bioscience, $695M
Lilly Reports Results of Tirzepatide in P-lll SURPASS-2 Trial for Type-2 Diabetes
Published: Mar 5, 2021 | Tags: Lilly, Reports, Results, Tirzepatide, P-lll, SURPASS-2, Trial, Type-2 Diabetes
Amgen to Acquire Five Prime for ~$1.9B
Published: Mar 5, 2021 | Tags: Amgen, Acquire, Five Prime, ~$1.9B
Vir and GSK Provide Update on ACTIV-3 Trial of VIR-7831 in Hospitalized Adults with COVID-19
Published: Mar 4, 2021 | Tags: Vir and GSK, Provide, Update, ACTIV-3, Trial, VIR-7831, Hospitalized Adults, COVID-19
Published: Mar 4, 2021 | Tags: Roche, Collaborates, Tempest, Evaluate, TPST-1120, Combination, Study, 1L, Treatment, Hepatocellular Carcinoma
Published: Mar 4, 2021 | Tags: Regeneron and Sanofi, Report, US, FDA, Acceptance, sBLA, Review, Dupixent, Treat, Moderate-to-Severe, Asthma, Children
Published: Mar 4, 2021 | Tags: Pfizer, Lorbrena (lorlatinib), Receives, FDA, Approval, Expanding, Indication, Treat, ALK-Positive Metastatic, Lung Cancer
Published: Mar 4, 2021 | Tags: Takeda, Signs, Exclusive, License, Agreement, Ovid, Soticlestat, Treat Dravet Syndrome, Lennox-Gastaut Syndrome
Boston Scientific Signs an Agreement with BPEA to Acquire Lumenis Surgical Business
Published: Mar 4, 2021 | Tags: Boston Scientific, Signs, Agreement, BPEA, Acquire, Lumenis, Surgical Business
Published: Mar 3, 2021 | Tags: Amgen, Reports, Results, Blincyto (blinatumomab), P-III, Study, Relapsed Acute Lymphoblastic Leukemia, Pediatric, Patients
Published: Mar 3, 2021 | Tags: BeiGene, Brukinsa (zanubrutinib), Receives, Health Canada, Approval, Waldenström's Macroglobulinemia
Fusion to Acquire Ipsen's IPN-1087 to Expand its Pipeline of Radiopharmaceuticals
Published: Mar 3, 2021 | Tags: Fusion, Acquire, Ipsen, IPN-1087, Expand, Pipeline, Radiopharmaceuticals
G1 Therapeutics and Boehringer Ingelheim Launch Cosela (trilaciclib) in the US
Published: Mar 3, 2021 | Tags: G1 Therapeutics and Boehringer Ingelheim, Launch, Cosela (trilaciclib), US
Biocon Biologics and Viatris Receive CHMP's Positive Opinion for Abevmy (biosimilar, bevacizumab)
Published: Mar 3, 2021 | Tags: Biocon Biologics and Viatris, Receive, CHMP, Positive Opinion, Abevmy (biosimilar, bevacizumab)
AbbVie Signs a Purchase Right Agreement to Acquire Mitokinin
Published: Mar 3, 2021 | Tags: AbbVie, Signs, Purchase, Right, Agreement, Acquire, Mitokinin
Published: Mar 2, 2021 | Tags: Veru, Advance, VERU-111, P-III, Study, COVID-19, Patients, High Risk, Acute Respiratory Distress Syndrome
AstraZeneca Collaborates with Junshi to Commercialize Toripalimab in China
Published: Mar 2, 2021 | Tags: AstraZeneca, Collaborates, Junshi, Commercialize, Toripalimab, China
Hologic to Acquire Diagenode for ~$159M
Published: Mar 2, 2021 | Tags: Hologic, Acquire, Diagenode, ~$159M
Samsung Bioepis Initiates P-I Study of SB17 Proposed Biosimilar to Stelara (ustekinumab)
Published: Mar 2, 2021 | Tags: Samsung Bioepis, Initiates, P-I, Study, SB17, Proposed, Biosimilar, Stelara (ustekinumab)
Published: Mar 2, 2021 | Tags: Merck, Reports, US, FDA, Acceptance, NDA, Review, Gefapixant, Treat, Unexplained, Chronic Cough
Merck KGaA Sign an Exclusive Worldwide License Agreement with Debiopharm for Xevinapant
Published: Mar 2, 2021 | Tags: Merck KGaA, Sign, Exclusive, Worldwide, License, Agreement, Debiopharm, Xevinapant
Published: Mar 1, 2021 | Tags: BMS, Opdivo (nivolumab), Cabometyx (cabozantinib), Receive, CHMP, Positive Opinion, 1L, Treatment, Advanced Renal Cell Carcinoma
Published: Mar 1, 2021 | Tags: Regeneron, Ab Cocktail (casirivimab + imdevimab), Receives, CHMP, Positive, Opinion, Treat, COVID-19
Johnson & Johnson Receives the US FDA's EUA for COVID-19 Vaccine
Published: Mar 1, 2021 | Tags: Johnson & Johnson, Receives, US, FDA, EUA, COVID-19, Vaccine
AstraZeneca and Amgen Report Results of Tezepelumab in P-III NAVIGATOR Trial for Severe Asthma
Published: Mar 1, 2021 | Tags: AstraZeneca and Amgen, Report, Results, Tezepelumab, P-III, NAVIGATOR, Trial, Severe Asthma
Roivant to Acquire Silicon Therapeutics for ~$450M
Published: Mar 1, 2021 | Tags: Roivant, Acquire, Silicon Therapeutics, ~$450M
Published: Mar 1, 2021 | Tags: BridgeBio and Origin, Nulibry (fosdenopterin), Receives, US, FDA, Approval, First, Therapy, Reduce, Risk, Mortality, Patients, MoCD Type A
Related Post: PharmaShots Weekly Snapshots (Feb 22 - 26, 2021)
Tags
This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com